Expiration StatementClick here to register for this eventACCREDITATION FOR THIS ACTIVITY HAS EXPIREDActivity TitleDevelopment of Novel Inhibitors Targeting Borrelia burgdorferi as Diagnostic and Therapeutic Agents.
DescriptionThis program describes how to discover a novel drug for treating active Lyme disease. This same drug can also be used as a companion diagnostic of infection. Intended AudienceThis activity is intended for scientific laboratory professionals who have an interest in Novel Inhibitors. Learning Objectives1. Explain what a small molecule drug is and how it works. Instruction Level: Intermediate SpeakerTimothy Haystead, PhD Duration1.5 hours Release and Expiration DatesRelease Date: September 29, 2022 DisclosuresThe opinions expressed in the educational activity are those of the speaker and do not necessarily represent the views of any organization associated with this activity. Timothy Haystead, PhD P.A.C.E.® AccreditationQuidel is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Policy on Privacy and ConfidentialityQuidel Corporation protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Quidel Corporation and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency. Quidel Corporation and its educational partners maintain physical, electronic and procedural safeguards that comply with recognized accreditation regulations to guard your non-public personal information. Medium UsedThis program has been made available online. Commercial Support StatementThis activity is provided by the Quidel Corporation. System RequirementsTo view this educational activity, you will need a modern web browser with JavaScript and HTML5. Cookies enabled allows users to proceed through all elements. Some users encounter issues with hand held devices ie. smart phones. In these cases, we recommend the use of computers. CopyrightCopyright © 2022. Quidel Corporation. | ||
Web interface provided by Dane Garvin Ltd.
|